What is the appropriate treatment for prolonged menstrual bleeding lasting ten days?

If a woman experiences menstrual bleeding that persists for ten days or longer—commonly referred to as menorrhagia when heavy, or more broadly as abnormal uterine bleeding (AUB)—this warrants prompt clinical evaluation. Prolonged menses may stem from multiple underlying causes, including hormonal imbalances (e.g., anovulation, polycystic ovary syndrome, thyroid dysfunction), structural abnormalities (e.g., uterine fibroids, endometrial polyps, adenomyosis), coagulopathies (e.g., von Willebrand disease), endometrial hyperplasia or malignancy (particularly in perimenopausal or postmenopausal individuals), or iatrogenic factors (e.g., use of anticoagulants, intrauterine devices, or certain hormonal contraceptives).

Initial assessment should include a detailed menstrual history (onset, duration, volume, clots, associated symptoms), reproductive and medical history, physical examination—including pelvic exam—and targeted investigations such as serum β-hCG (to rule out pregnancy-related causes), complete blood count (to assess for anemia), thyroid-stimulating hormone (TSH), and possibly coagulation studies. Transvaginal ultrasound is often first-line imaging to evaluate endometrial thickness, myometrial architecture, and adnexal structures. In women aged ≥45 years, or those with risk factors for endometrial pathology (e.g., obesity, unopposed estrogen exposure, tamoxifen use), endometrial biopsy or saline-infusion sonohysterography may be indicated to exclude hyperplasia or carcinoma.

Treatment is tailored to the identified cause, patient’s age, fertility goals, symptom severity, and comorbidities. First-line medical management often includes combined oral contraceptives or progestin-only regimens (e.g., norethindrone, levonorgestrel-releasing IUD) to stabilize the endometrium and reduce bleeding. Tranexamic acid—a synthetic antifibrinolytic—may be added for acute reduction in blood loss. For patients with iron deficiency anemia, oral or intravenous iron supplementation is essential. Surgical options—including hysteroscopic polypectomy, myomectomy, or endometrial ablation—are considered when medical therapy fails or structural pathology is confirmed. Hysterectomy remains definitive treatment for refractory cases where childbearing is complete and other interventions are unsuitable.

Any episode of prolonged uterine bleeding should not be dismissed as “normal variation.” Early diagnosis and individualized intervention improve outcomes, prevent complications such as severe anemia or hemorrhagic shock, and support long-term gynecologic health.